Cargando…

Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention

Since the start of the coronavirus disease 2019 (COVID‐19) pandemic, new variants of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) have emerged, accelerating the spread of the virus. Omicron was defined by the World Health Organization in November 2021 as the fifth “variant of concern...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Ailan, Hong, Bixia, Lou, Fuxing, Wang, Shuqi, Li, Wenye, Shafqat, Amna, An, Xiaoping, Zhao, Yunwei, Song, Lihua, Tong, Yigang, Fan, Huahao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380698/ https://www.ncbi.nlm.nih.gov/pubmed/35992968 http://dx.doi.org/10.1002/mco2.172

Ejemplares similares

Pharmacological Activity of Cepharanthine
por: Liu, Ke, et al.
Publicado: (2023)

SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines
por: Li, Maochen, et al.
Publicado: (2022)

The Benefits of Breastfeeding Still Outweigh the Risks of COVID-19 Transmission
por: Lou, Fuxing, et al.
Publicado: (2021)

2’-Fucosyllactose Inhibits Coxsackievirus Class A Type 9 Infection by Blocking Virus Attachment and Internalisation
por: Lou, Fuxing, et al.
Publicado: (2022)

Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Overview of Breastfeeding Under COVID-19 Pandemic
por: Pang, Zehan, et al.
Publicado: (2022)

Molnupiravir and Its Antiviral Activity Against COVID-19
por: Tian, Lili, et al.
Publicado: (2022)

The emergence of powerful oral anti-COVID-19 drugs in the post-vaccine era
por: Fan, Huahao, et al.
Publicado: (2022)

SARS-CoV-2 Variants of Concern Delta: a great challenge to prevention and control of COVID-19
por: Li, Maochen, et al.
Publicado: (2021)

SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency
por: Li, Maochen, et al.
Publicado: (2021)

Efficient disinfection of SARS-CoV-2-like coronavirus, pseudotyped SARS-CoV-2 and other coronaviruses using cold plasma induces spike protein damage
por: Qin, Hongbo, et al.
Publicado: (2022)

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
por: Bhiman, Jinal N., et al.
Publicado: (2023)

Antiviral Drugs Screening for Swine Acute Diarrhea Syndrome Coronavirus
por: Chen, Yangzhen, et al.
Publicado: (2022)

Lineages, Sub-Lineages and Variants of Enterovirus 68 in Recent Outbreaks
por: Lauinger, Ina L., et al.
Publicado: (2012)

Dissemination of the Omicron Variant and Its Sub-Lineages among Residents and Travelers in Its First Year of Emergence in Venezuela
por: Moros, Zoila C., et al.
Publicado: (2023)

Induction of significant neutralizing antibodies against SARS-CoV-2 by a highly attenuated pangolin coronavirus variant with a 104nt deletion at the 3'-UTR
por: Lu, Shanshan, et al.
Publicado: (2022)

Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England
por: Webster, H. H., et al.
Publicado: (2022)

The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages
por: Xiang, Tiandan, et al.
Publicado: (2022)

Potential application of a newly isolated phage BUCT609 infecting Stenotrophomonas maltophilia
por: Han, Ke, et al.
Publicado: (2022)

Pathogen-host adhesion between SARS-CoV-2 spike proteins from different variants and human ACE2 studied at single-molecule and single-cell levels
por: Zhang, Xiaoxu, et al.
Publicado: (2022)

Post-Vaccination Neutralization Responses to Omicron Sub-Variants
por: Jacobsen, Henning, et al.
Publicado: (2022)

Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant
por: Richardson, Simone I., et al.
Publicado: (2022)

Genomic Analysis of Bacteriophage BUCT86 Infecting Klebsiella Pneumoniae
por: Han, Ke, et al.
Publicado: (2022)

Characterization, complete genome sequencing, and CRISPR/Cas9 system-based decontamination of a novel Escherichia coli phage TR1 from fermentation substrates
por: Dong, Yuqi, et al.
Publicado: (2023)

Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador
por: Carrazco-Montalvo, Andrés, et al.
Publicado: (2022)

Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages
por: Touret, Franck, et al.
Publicado: (2023)

Outcomes of Omicron sub-lineages BA.1.1 and BA.2 infection compared with the sub-lineage BA.1 infection in emergency departments' patients
por: Bouzid, Donia, et al.
Publicado: (2023)

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
por: Lou, Fuxing, et al.
Publicado: (2021)

Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice
por: Liu, Jianyang, et al.
Publicado: (2022)

Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022
por: Fonager, Jannik, et al.
Publicado: (2022)

Artemether, Artesunate, Arteannuin B, Echinatin, Licochalcone B and Andrographolide Effectively Inhibit SARS-CoV-2 and Related Viruses In Vitro
por: Hu, Yunjia, et al.
Publicado: (2021)

Advances in the development of antivirals for rotavirus infection
por: Jiang, Lin, et al.
Publicado: (2023)

Neutralization susceptibility of Omicron lineages
por: Minton, Kirsty
Publicado: (2022)

Efficacy in Galleria mellonella Larvae and Application Potential Assessment of a New Bacteriophage BUCT700 Extensively Lyse Stenotrophomonas maltophilia
por: Li, Yahao, et al.
Publicado: (2023)

Reproduction Number of the Omicron Variant Triples That of the Delta Variant
por: Du, Zhanwei, et al.
Publicado: (2022)

“Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants”
por: Vera-Lise, Ihm, et al.
Publicado: (2022)

An ARMS-Multiplex PCR Targeting SARS-CoV-2 Omicron Sub-Variants
por: Bozidis, Petros, et al.
Publicado: (2023)

Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
por: Evans, John P., et al.
Publicado: (2022)

SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells
por: Gori Savellini, Gianni, et al.
Publicado: (2023)

SARS‐CoV‐2 Omicron variant: Characteristics and prevention
por: He, Xuemei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7u2iecn7v9ibcpfvmebd22obcj